Who
Cameron John Reynolds
President and CEO
Company insider
Files Form 4 as: President and CEO, VolitionRX.
In numbers
- Trades disclosed
- 105
- Buys
- 16
- Sells
- 2
- Bought
- $387K
- Sold
- $12K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Aug 2014
- Last trade
- 26 Feb 2026
- Last filed
- 27 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Feb 2026filed 27 Feb 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —486,000 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —486,000 at $0.00 | filing |
| 22 Jan 2026filed 23 Jan 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —74,700 at $0.00 | filing |
| 22 Jan 2026filed 23 Jan 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —74,700 at $0.00 | filing |
| 17 Nov 2025filed 17 Nov 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $7,00020,000 at $0.35 | filing |
| 14 Oct 2025filed 15 Oct 2025 | VNRX VolitionRXoption or derivative · Diagnostics & Labs | SEC FORM 4 Code P | $1,100110,000 at $0.01 | filing |
| 14 Oct 2025filed 15 Oct 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $56K110,000 at $0.51 | filing |
| 12 Sep 2025filed 15 Sep 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $9,90015,000 at $0.66 | filing |
| 5 Aug 2025filed 6 Aug 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $50K78,125 at $0.64 | filing |
| 24 Jul 2025filed 25 Jul 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $7,37512,500 at $0.59 | filing |
| 19 May 2025filed 19 May 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $8,80020,000 at $0.44 | filing |
| 26 Mar 2025filed 27 Mar 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $100K181,818 at $0.55 | filing |
| 29 Jan 2025filed 31 Jan 2025 | VNRX VolitionRXoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —50,000 | filing |
| 29 Jan 2025filed 31 Jan 2025 | VNRX VolitionRXoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —50,000 | filing |
| 9 Dec 2024filed 10 Dec 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $80K139,811 at $0.57 | filing |
| 1 Sep 2024filed 4 Sep 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —103,243 at $0.00 | filing |
| 15 Aug 2024filed 16 Aug 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —29,500 at $0.00 | filing |
| 1 Jun 2024filed 4 Jun 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —90,182 at $0.00 | filing |
| 24 Jan 2024filed 26 Jan 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —50,150 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.